Finance

Lists
SNOA:NASDAQ
Sonoma Pharmaceuticals Inc
1,22 US$
-0,11%
(-0,0013) 1D
6 ოქტ, 13:56:30 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNOA...
Open
1,27 US$
High
1,27 US$
Low
1,21 US$
Mkt. cap
5,93 მლნ.
Avg. vol.
52,06 ათ.
Volume
34,40 ათ.
52-wk high
4,45 US$
52-wk low
0,85 US$
EPS
-1,22 US$
Beta
1,30
Shares outstanding
4,79 მლნ.
No. of employees
260
Open
1,27 US$
High
1,27 US$
Low
1,21 US$
Mkt. cap
5,93 მლნ.
Avg. vol.
52,06 ათ.
Volume
34,40 ათ.
52-wk high
4,45 US$
52-wk low
0,85 US$
EPS
-1,22 US$
Beta
1,30
Shares outstanding
4,79 მლნ.
No. of employees
260
News stories
From web sources and news partners
About Sonoma Pharmaceuticals Inc
CEO-
Employees260
Founded1999
Headquartersბაულდერი, კოლორადოს შტატი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,60 მლნ.
4,35 მლნ.
5,56 მლნ.
6,41 მლნ.
Cost of goods sold
3,48 მლნ.
2,70 მლნ.
3,38 მლნ.
3,83 მლნ.
Cost of revenue
3,48 მლნ.
2,70 მლნ.
3,38 მლნ.
3,83 მლნ.
Research and development expenses
575,00 ათ.
557,00 ათ.
545,00 ათ.
597,00 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,88 მლნ.
1,77 მლნ.
1,99 მლნ.
2,02 მლნ.
Operating expense
2,46 მლნ.
2,33 მლნ.
2,53 მლნ.
2,62 მლნ.
Total operating expenses
5,94 მლნ.
5,03 მლნ.
5,91 მლნ.
6,45 მლნ.
Operating income
-337,00 ათ.
-678,00 ათ.
-351,00 ათ.
-40,00 ათ.
Other non operating income
-394,00 ათ.
-271,00 ათ.
-1,59 მლნ.
-
EBT including unusual items
-731,00 ათ.
-949,00 ათ.
-497,00 ათ.
-330,00 ათ.
EBT excluding unusual items
-731,00 ათ.
-949,00 ათ.
-497,00 ათ.
-330,00 ათ.
Income tax expense
-197,00 ათ.
-130,00 ათ.
84,00 ათ.
-
Effective tax rate
26,95%
13,70%
-16,90%
-
Other operating expenses
-
-
-
-
Net income
-534,00 ათ.
-819,00 ათ.
-581,00 ათ.
-330,00 ათ.
Net profit margin
-9,53%
-18,83%
-10,45%
-5,15%
Earnings per share
-
-0,48
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-301,00 ათ.
-644,00 ათ.
-318,00 ათ.
-8,00 ათ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები